bioRxivSystems BiologyPreprint
A heterogeneous biomedical knowledge network framework for rare disease drug candidate prioritization: integrating Orphadata and DisGeNET via gene-bridge harmonization
Abstract
Rare diseases collectively affect over 300 million individuals worldwide, yet the vast majority lack approved pharmacological treatments, leaving patients with few therapeutic options and researchers with limited computational tools for systematic candidate identification. This study presents a network-based computational framework that integrates two complementary public biomedical databases (Orphadata, which catalogs gene-disease associations for Orphanet-classified rare disorders, and DisGeNET, which documents gene-drug interaction records) through a reproducible three-stage gene symbol harmonization pipeline comprising HGNC identifier standardization, MyGene.info API mapping, and RapidFuzz fuzzy string matching. The resulting heterogeneous tripartite knowledge network encompasses 15,454 nodes and 35,131 edges, covering 2,249 clinically distinct rare diseases. A Graph Attention Network (GAT) is trained on this network using node-type classification as a pretext task, enabling the model to learn biologically informed node representations encoding the structural co-association of disease, gene, and drug entities. These representations are used to rank drug candidates for a query rare disorder via cosine similarity in the embedding space. The framework is explicitly positioned as a decision support tool for prioritizing existing gene-bridged drug-disorder connections rather than predicting novel associations. Held-out evaluation across 200 disorders demonstrates Hits@10 = 0.400 compared to a random baseline under 0.001, a greater than 400-fold improvement. The rank-4 retrieval of NITISINONE, the approved standard of care for hereditary tyrosinaemia type 1, for a query disorder sharing the HPD tyrosine catabolism pathway, without pathway annotations provided to the model, supports the biological plausibility of the learned embeddings. The complete pipeline is reproducible and is deployed as an interactive decision support interface on HuggingFace Spaces.
- research focus: drug response / drug discovery
- research focus: benchmarking
- research focus: database / resource
- research focus: software / tool
- approach: graph neural network
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases
Daniel N. Sosa, Alexander Derry, … Russ Biagio Altman·Pacific Symposium on Biocomputing (PSB)Peer-reviewed·Nov 27, 2019
- Clinical Trial and Ontology-Derived Positive and Negative Benchmark Datasets for Drug Repurposing Across Rare Diseases
Babak Ravandi, William R. Mowrey, … Gabriel Tarrason Risa·bioRxiv·Jul 8, 2026
- Clustering rare diseases within an ontology-enriched knowledge graph
Jaleal S. Sanjak, Jessica Binder, … Ewy A. Mathé·Journal of the American Medical Informatics AssociationPeer-reviewed·Sep 27, 2023
- Using Networks and Prior Knowledge to Uncover Novel Rare Disease Phenotypes
Galadriel Brière, Cécile Beust, … Anaı̈s Baudot·medRxiv·Apr 2, 2025
- Phen2Gene: Rapid Phenotype-Driven Gene Prioritization for Rare Diseases
Mengge Zhao, James M. Havrilla, … Kai Wang·NAR Genomics and BioinformaticsPeer-reviewed·May 25, 2020
- RD-Embed: Unified representations of rare-disease knowledge from clinical records
Tudor Groza, Freddie Tan, … Saumya Shekhar Jamuar·medRxiv·Apr 4, 2026